{ "items": [ "\n\n
\n \n\n \n \n \n \n Children's Health\n \n \n \n \n Clinical Trials\n \n \n \n \n Neuromuscular Diseases\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n30 August 2023
\n \n \n \nScientists at the University of Oxford are running a study at participating hospitals in the Thames Valley and Wessex regions, offering parents the ability to have their newborn baby\u2019s blood tested for Spinal Muscular Atrophy (SMA), in addition to the nine other conditions that are already tested for.
\n \n\n \n \n\n \n\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n27 March 2023
\n \n \n \n\n \n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n19 October 2022
\n \n \n \nHealth and care research in Oxford is to receive \u00a3122 million in government funding over the next five years to improve diagnosis, treatment and care for NHS patients. The funding was awarded to the two NIHR Biomedical Research Centres.
\n \n\n \n \n\n \n\n \n \n \n \n Children's Health\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n6 September 2022
\n \n \n \nResearchers in Oxford have launched the first UK study in the general population to test for early markers of type 1 diabetes before children develop symptoms or need insulin.
\n \n\n \n \n\n \n\n \n \n \n \n Neuromuscular Diseases\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n3 December 2021
\n \n \n \nThings that seemed impossible, only a few years ago, are happening today. The first patient in Europe and one of the first in the world was injected with a potential treatment, GTX-102, in a phase I/II clinical trial in Oxford.
\n \n\n \n \n\n \n\n \n \n \n \n Haematology\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n25 November 2021
\n \n \n \nThe breakthrough could lead to development of new treatments for infant Acute Lymphoblastic Leukaemia.
\n \n\n \n \n\n \n\n \n \n \n \n Children's Health\n \n \n \n \n Neuroimaging\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n12 November 2021
\n \n \n \nFor decades physicians believed that premature babies didn\u2019t experience pain. Here\u2019s what doctors know now \u2013 and the innovative solutions being embraced by today's caregivers.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n8 November 2021
\n \n \n \nThe University of Oxford and Brazilian Ministry of Health have announced a joint initiative to set up a global health and clinical research unit in Brazil led by Professor Sue Ann Clemens CBE.
\n \n\n \n \n\n \n\n \n \n \n \n Children's Health\n \n \n \n \n Haematology\n \n \n \n \n Immunology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n5 October 2021
\n \n \n \nA new study published this week in Nature, provides the most detailed analysis so far of the prenatal development of blood and immune cells in the bone marrow.
\n \n\n \n \n\n \n\n \n \n \n \n Neuromuscular Diseases\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n23 August 2021
\n \n \n \nResearch led by Carlo Rinaldi and Catheryn Lim discovered that a naturally-occurring isoform of an androgen receptor can be used in therapy for spinal and bulbar muscular atrophy, and shows potential for other diseases.
\n \n\n \n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n9 August 2021
\n \n \n \nDr Samantha Vanderslott (Oxford Vaccine Group) and Dr Claas Kirchhelle (University College Dublin) have had their three-year project \u2018Typhoid, Cockles, and Terrorism\u2019 about the history of typhoid in Dublin successfully funded.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Public Engagement\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n6 May 2021
\n \n \n \nDr Samantha Vanderslott and Dr Seilesh Kadambari discuss their collaborative approach to providing ethnic minority groups with information on vaccines.
\n \n\n \n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n Haematology\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n18 March 2021
\n \n \n \nAssociate Professor Andi Roy leads one of the five research teams across the UK that have been awarded the 2021 Cancer Research UK-Children with Cancer UK Innovation Award. The awards, which provide a total of \u00a34.3 million in scientific funding, will allow leading researchers in the field to delve into the biology of children\u2019s and young people\u2019s cancers, with the hope of finding new ways to prevent and treat these complex cancers.
\n \n\n \n \n\n \n\n \n \n \n \n General\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n8 March 2021
\n \n \n \nIn these short interviews, Anna Kordala and Jane Millar talk about the research they do at the Department of Paediatrics.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n24 February 2021
\n \n \n \nThe first study to describe the effects in real-world communities of the Oxford coronavirus vaccine has been reported in a pre-print publication today, showing a clear reduction in the risk of hospitalisation from COVID-19 amongst those who have received the vaccine.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n5 February 2021
\n \n \n \nA preprint of ongoing work to assess effectiveness of Oxford\u2019s ChAdOx1 coronavirus vaccine shows that the existing vaccine has similar efficacy against the B.1.1.7 \u2018Kent\u2019 coronavirus strain currently circulating in the UK to previously circulating variants.
\n \n\n \n \n\n \n\n \n \n \n \n Neuroimaging\n \n \n \n \n Publication\n \n \n \n \n Research\n \n \n\n \n\n\n
\n \n\n \n22 October 2020
\n \n \n \nThe launch of Lancet Child and Adolescent Health Commission - the first ever to address paediatric pain - aims to raise the profile of children\u2019s pain from early years to early adulthood.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Recruitment\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n24 April 2020
\n \n \n \nUniversity of Oxford researchers have begun testing a COVID-19 vaccine in human volunteers in Oxford today. Around 1,110 people will take part in the trial, half receiving the vaccine and the other half (the control group) receiving a widely available meningitis vaccine.
\n \n\n \n \n\n \n\n \n \n \n \n Awards & Appointments\n \n \n \n \n COVID-19\n \n \n \n \n Research\n \n \n \n \n Vaccinology\n \n \n\n \n\n\n
\n \n\n \n17 April 2020
\n \n \n \nFive projects from across Oxford University's Medical Sciences Division, including a project led by Professor Matthew Snape from the Oxford Vaccine Group, are among twenty-one new studies into the novel coronavirus which have been funded by the UK government.
\n \n\n \n \n\n \n\n \n \n \n \n COVID-19\n \n \n \n \n Neuroimaging\n \n \n \n \n Research\n \n \n \n \n Research Methods\n \n \n\n \n\n\n
\n \n\n \n2 April 2020
\n \n \n \nPaediatric Neuroimaging researcher provides real-time case information on epidemiological data from the COVID-19 outbreak.
\n \n\n \n \n